Gene · 10544
PROCR: protein C receptor
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PROCR: protein C receptor. Genes, record 10544. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10544
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9UNN8 | Endothelial protein C receptor | 238 | 13 | Ensembl, GeneID, HGNC |
Source UniProt
Patents96
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 59627 | Q9UNN8 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 59628 | Q9UNN8 | Espacenet |
| JP 2025541179 A | 2025-12-18 | 15 | Q9UNN8 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 378 | Q9UNN8 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 46 | Q9UNN8 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 267 | Q9UNN8 | Espacenet |
| EP 4630459 A1 | 2025-10-15 | 15 | Q9UNN8 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3580 | Q9UNN8 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 3580 | Q9UNN8 | Espacenet |
| EP 4587478 A1 | 2025-07-23 | 15 | Q9UNN8 | Espacenet |
1 to 10 of 96
See all 96 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,549
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PROCR papers | Newest fiscal year |
|---|---|---|---|
| R01HL101917 | Protease Activated Receptor and Thrombomodulin Signaling by coagulation proteases | 26 | 2025 |
| R01HL142975 | Regulation of Protein C Pathways | 17 | 2025 |
| P01AI045897 | A Tolerance Approach to Xenotransplantation | 11 | 2025 |
| T32AI074490 | Interdisciplinary Training in Transplantation Biology | 8 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 7 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 6 | 2025 |
| R01HL101972 | Characterization of Coagulation Factor-platelet Interactions: Role of FXI | 5 | 2025 |
| ZIAAI000241 | Malaria Parasite Ligands And Host Cell Receptors | 5 | 2025 |
| P40OD024628 | Specific Pathogen Free 18 Baboon Research Resource (SPF18BRR) | 4 | 2025 |
| R01HL034594 | RISK FACTORS FOR CVD IN WOMEN | 4 | 2025 |
1 to 10 of 1,549Source NIH's project files
See all 1,549 nih grantsPapers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetically engineered porcine liver: a new era in transplantation. | Int J Surg | 2026 | 42808109 | PubTator, text mining | PubMed |
| Single-cell multi-omic profiling of heterogeneous PROCR+ cells in mouse mammary gland and its implication for breast cancer. | iScience | 2026 | 42733452 | PubTator, text mining | PubMed |
| PROFET predicts continuous gene expression dynamics from scRNA-seq data to elucidate heterogeneity of cancer treatment responses. | Cell Syst | 2026 | 42664975 | PubTator, text mining | PubMed |
| Visualization of new vessel formation during venous thrombus organization using genetic fate mapping. | Res Pract Thromb Haemost | 2026 | 42656861 | PubTator, text mining | PubMed |
| Comparative Analysis of LPS/IFN-γ and LPS/ATP-Induced Inflammatory Models in BV2 Microglia. | Neurochem Res | 2026 | 42566061 | PubTator, text mining | PubMed |
| Functional definition of endothelial progenitors by PROCR and PDGFRA co-expression. | Angiogenesis | 2026 | 42541597 | PubTator, text mining | PubMed |
| In vivo and ex vivo impact of THBD and PROCR polymorphisms on the anticoagulant response of the protein C pathway. | Blood Adv | 2026 | 42480122 | PubTator, text mining | PubMed |
| Endothelial protein C receptor expression as a marker of reduced metastatic risk in primary melanoma. | Melanoma Res | 2026 | 42440262 | PubTator, text mining | PubMed |
| Endothelial protein C receptor and the endothelial progenitor paradigm: towards a functional definition at last. | Angiogenesis | 2026 | 42377391 | PubTator, text mining | PubMed |
| Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection. | Curr Opin Immunol | 2026 | 42330677 | PubTator, text mining | PubMed |
1 to 10 of 2,749
See all 2,749 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10544
GET https://conductscience.org/api/genes/v1/10544/patents?page=2